GENE ONLINE|News &
Opinion
Blog

Inhibitor
Merck Enters $2 Billion Agreement to Develop Lipoprotein(a) Inhibitor for Atherosclerosis Treatment
2025-03-26
CRISPR-Edited T cells Evaluated in Combating Lung Cancer
2020-05-10
AACR 2020: Targeting the KRAS Pathway – Old Protein, New Approaches
2020-04-30
Korean Firm, Asia’s First to Get FDA Clearance for Testing Anti-Cancer Microbiome Therapeutic
2020-04-24
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
Anti-Parasitic Drug, Ivermectin Shows Anti-COVID-19 Ability in The Lab
2020-04-09
R&D
Unveiling of KRAS Inhibitor Clinical Data Initiates Mirati, Amgen comparisons
2019-10-29
Weekly in Asia(0428-0503)
2019-05-09
Weekly Top 5 in China (0317-0323)
2019-03-25
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics
2025-04-24
EVENT
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
Scroll to Top